Sleep disturbance, cytokines, and fatigue in women with ovarian cancer.
Showing posts with label sleep disturbances. Show all posts
Showing posts with label sleep disturbances. Show all posts
Sunday, May 06, 2012
paywalled: Sleep disturbance, cytokines, and fatigue in women with ovarian cancer.
Sleep disturbance, cytokines, and fatigue in women with ovarian cancer.
add your opinions
fatigue
,
Interleukins
,
sleep disturbances
Tuesday, March 20, 2012
abstract: [Assessment of health-related quality of life in cancer outpatients treated with chemotherapy] Japanese study
[Assessment of health-related quality of life in cancer outpatients treated with chemotherapy].
Abstract
Purpose:
Few studies have been conducted to elucidate the health-related quality of life(HR-QOL) of cancer outpatients treated with chemotherapy. In this study, we attempted to determine the physical and psychological distress of cancer outpatients treated with chemotherapy.
Methods:
Two-hundred and ninety-six outpatients with various malignancies, including malignant lymphoma, and esophageal, gastric, pancreatic, colon, lung, breast, ovarian, uterine and skin cancers, were investigated using the Japanese version of the M. D. Anderson symptom inventory from March through June 2010 in Tokyo Medical University Hospital.
Results:
The results of the survey questionnaire indicated that 59 patients suffered from fatigue, 56 experienced numbness or tingling, 48 felt drowsy, 39 had low moods, 40 felt distressed, 38 had no appetite, 38 had dry mouth, 37 were in pain, 37 had disturbed sleep, 31 had shortness of breath, 24 had nausea, 17 suffered from vomiting, and 13 patients had memory problems. Furthermore, these symptoms interfered with work(65 patients), walking(56 patients), mood(52 patients), life enjoyment(49 patients), general activity(49 patients), and relationships with other people(42 patients). Medications prescribed for HR-QOL control were non-steroidal anti-inflammatory drugs (93 patients), morphine(32 patients), and adjuvant analgesics(47 patients).
Conclusion:
The present findings may help in the development of management strategies for physical and psychological distress, and improve HR-QOL of cancer outpatients treated with chemotherapy.
add your opinions
anxiety
,
distress
,
emesis
,
fatigue
,
medications
,
morphine
,
nausea
,
neuropathy
,
non-steroid anti-inflammatory
,
pain
,
QOL
,
quality of life
,
sleep disturbances
,
vomiting
,
walking
,
work
Monday, August 22, 2011
abstract : The effect of sleep disturbance on quality of life in women with ovarian cancer
"PSQI was not correlated with age, time since diagnosis, number of previous chemotherapy regimens. PSQI score did not differ by current disease or chemotherapy status."
add your opinions
depression
,
QOL
,
sleep disturbances
,
survival
Tuesday, May 11, 2010
Sunday, March 28, 2010
Sleep disturbances in asymptomatic BRCA1/2 mutation carriers: women at high risk for breast-ovarian cancer
"Fatigue and carrier status were significant predictors of sleep quality, accounting for 15.7% of the variance.
In conclusion, asymptomatic BRCA1/2 carriers experience poor sleep quality compared to non-carriers and controls. Our study design is unique in that it offers insight regarding the nature of being an asymptomatic carrier, and affords the opportunity to examine factors that may contribute to the development of insomnia in women at risk for breast-ovarian cancer."
add your opinions
BRCA 1
,
BRCA 2
,
sleep disturbances
Subscribe to:
Posts
(
Atom
)